RAPT FY 2021 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-24.4% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$69M-1815.1% margin

Net Income

-$69M-1814.9% margin

EPS (Diluted)

$-20.21

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$62M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$199M

Total Liabilities

$12M

Stockholders' Equity

$186M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-24.4%
Gross Profit	$4M	$5M	-24.4%
Operating Income	-$69M	-$53M	-30.1%
Net Income	-$69M	-$53M	-30.8%